Analysis of Abaxx Technologies Inc. (ABXXF)
Abaxx Technologies Inc. stock (symbol: ABXXF) has been showing some volatility in the recent trading sessions. The Relative Strength Index (RSI) values have been fluctuating around the 50 level, indicating a balanced market sentiment without a clear trend.
The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a lack of strong momentum in either direction. The MACD histogram has been oscillating around zero, further confirming the lack of a clear trend.
The stock's closing prices have been relatively stable, with minor fluctuations between $9.32 and $9.50. The Moving Average (MA) indicator has been close to the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a consolidation phase.
Overall, Abaxx Technologies Inc. stock appears to be in a consolidation phase with no clear trend direction. Traders and investors may need to wait for a breakout or further confirmation signals before making trading decisions.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. The company has been investing in leases, land, and improvements over the years.
9. There have been fluctuations in retained earnings and other shareholders' equity.
10. Overall, the company's financial health seems stable and improving over the years.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not supplied at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a relatively high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company has a good return on assets and return on equity.
In terms of stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, including its beta, moving averages, and 52-week high and low.
Valuation metrics indicate the company's valuation relative to its earnings, revenue, and market capitalization. The company has a high PEG ratio and price-to-book ratio, but a relatively low forward PE ratio. The enterprise value is significant compared to the market capitalization.
Lastly, the dividends and splits information shows the company's dividend history, payout ratio, and dividend yield. The company has a regular dividend payout and has undergone a stock split in the past.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been effectively managing its operating expenses, with a slight increase in research and development costs over the years.
9. Non-operating interest expenses have been relatively stable, indicating a consistent financial management approach.
10. The number of basic and diluted shares outstanding has remained stable over the years.
Overall, the financial performance of the company has been positive, with consistent revenue growth, effective cost management, and increasing profitability.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts' forecasts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This forecast is based on the input of 39 analysts.
Overall, the trend indicates a growth in earnings per share both quarterly and annually, showing positive expectations from analysts regarding the company's performance in the upcoming periods.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to have a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is expected to be 4.8%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of 11%.
- However, when looking at the past 5 years, the company had a higher CAGR of approximately 20.1%.
Overall, it seems that the company is expected to experience steady growth in the upcoming periods, with a slightly higher growth rate in the next 5 years compared to the current and next year estimates.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the lowest estimate at $164, the highest at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.MACD of ABXXF